MIMEDX GROUP, INC.: Trigran Investments, Inc. discloses a stake of more than 5% (Schedule 13G)
Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 12 November 2026, by SEC EDGAR SCHEDULE 13G
30
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Trigran Investments disclosed a stake exceeding 5% in MiMedx Group in a Schedule 13G filing with the SEC. The exact share count and percentage were not specified in the filing summary. The position makes Trigran a notable institutional holder in the wound-care and biologics company. Investors will watch whether the firm pushes for operational or strategic changes.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
MIMEDX GROUP, INC., Trigran Investments, Inc.